Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side Effect Zoloft Gabapentin
DRUG INEFFECTIVE 3.2% 4.5%
FATIGUE 3.1% 3.3%
NAUSEA 3.3% 3%
DEPRESSION 2.9% 1.3%
ANXIETY 2.9% 1.2%
PAIN 2.4% 2.8%
HEADACHE 2.6% 2.3%
DIARRHOEA 2.2% 2.5%
DIZZINESS 2.3% 2.4%
FALL 1.8% 2.3%
INSOMNIA 2.1% 1.4%
DYSPNOEA 2% 2%
ASTHENIA 1.8% 1.7%
VOMITING 1.8% 1.6%
MALAISE 1.5% 1.7%
PAIN IN EXTREMITY 1.2% 1.7%
FEELING ABNORMAL 1.6% 1.3%
DRUG HYPERSENSITIVITY 1.1% 1.6%
ARTHRALGIA 1.3% 1.5%
WEIGHT INCREASED 1.5% 1%
PNEUMONIA 1% 1.5%
SOMNOLENCE 1.2% 1.4%
OFF LABEL USE 1% 1.4%
WEIGHT DECREASED 1.3% 1.2%
BACK PAIN 1.1% 1.3%
TREMOR 1.3% 1%
DEATH 0.8% 1.3%
GAIT DISTURBANCE 0.8% 1.3%
SUICIDAL IDEATION 1.3% 0.5%
RASH 1% 1.2%
COMPLETED SUICIDE 0.5% 1.2%
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 0% 1.2%
CONDITION AGGRAVATED 1% 1.1%
CHEST PAIN 1.1% 0.8%
HYPERTENSION 1.1% 0.8%
DRUG DOSE OMISSION 0.7% 1.1%
TOXICITY TO VARIOUS AGENTS 0% 1.1%
CONFUSIONAL STATE 1% 1%
PRURITUS 0.9% 1%
PYREXIA 0.9% 1%
CONSTIPATION 0.8% 1%
MUSCLE SPASMS 0.8% 1%
HYPOAESTHESIA 0.8% 1%
PARAESTHESIA 0.9% 0.9%
DECREASED APPETITE 0.9% 0.9%
URINARY TRACT INFECTION 0.8% 0.9%
ABDOMINAL PAIN 0.9% 0.8%
MEMORY IMPAIRMENT 0.6% 0.9%
DIABETES MELLITUS 0.9% 0%
COUGH 0.8% 0.8%
HYPOTENSION 0.7% 0.8%
DRUG INTERACTION 0.8% 0.7%
ABDOMINAL PAIN UPPER 0.8% 0.7%
ANAEMIA 0.8% 0.7%
MYALGIA 0.8% 0.6%
HYPERHIDROSIS 0.8% 0.6%
OEDEMA PERIPHERAL 0.8% 0.6%
PERIPHERAL SWELLING 0% 0.8%
NEUROPATHY PERIPHERAL 0% 0.8%
DEHYDRATION 0.7% 0.7%
VISION BLURRED 0.7% 0.7%
LOSS OF CONSCIOUSNESS 0.7% 0.6%
ALOPECIA 0.6% 0.7%
CEREBROVASCULAR ACCIDENT 0.7% 0.5%
BALANCE DISORDER 0.5% 0.7%
MYOCARDIAL INFARCTION 0.7% 0.5%
MUSCULAR WEAKNESS 0.5% 0.7%
RENAL FAILURE 0.5% 0.7%
ACUTE KIDNEY INJURY 0% 0.7%
CONVULSION 0.7% 0%
AGITATION 0.7% 0%
SUICIDE ATTEMPT 0.7% 0%
MATERNAL EXPOSURE DURING PREGNANCY 0.7% 0%
IRRITABILITY 0.7% 0%
OVERDOSE 0.6% 0.6%
ABDOMINAL DISCOMFORT 0.6% 0.6%
BLOOD PRESSURE INCREASED 0.6% 0.5%
INJECTION SITE PAIN 0.5% 0.6%
PRODUCT USE ISSUE 0% 0.6%
PALPITATIONS 0.6% 0%
NASOPHARYNGITIS 0% 0.6%
TYPE 2 DIABETES MELLITUS 0.6% 0%
PRODUCT USE IN UNAPPROVED INDICATION 0% 0.6%
MULTIPLE SCLEROSIS RELAPSE 0% 0.6%
INJURY 0.6% 0%
DISTURBANCE IN ATTENTION 0.6% 0%
PULMONARY EMBOLISM

privacy policy